[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584947":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":51,"collaborators":20,"id":54,"slug":20,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":20,"enrollmentInfo":62,"targetDuration":20,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":74,"overallStatus":37,"whyStopped":20,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"University of Chile","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with periodontitis and Diabetes Mellitus type 2","EXPERIMENTAL","There will be a group of patients to intervene, who present periodontitis and Diabetes Mellitus type 2.",[13],"Procedure: Non-surgical periodontal treatment, glycated hemoglobin measurement and application of OHIP-14SP survey.",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"PROCEDURE","Non-surgical periodontal treatment, glycated hemoglobin measurement and application of OHIP-14SP survey.","Non-surgical periodontal treatment will be performed, with periodontal maintenance therapy at 3, 6, 9 and 12 months, with measurement of glycated hemoglobin at each time and application of the OHIP-14SP oral health-related quality of life survey.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Melisa Vera, Specialist in periodontics","PRINCIPAL_INVESTIGATOR",[26,31],{"name":23,"role":27,"phone":28,"phoneExt":29,"email":30},"CONTACT","+56976442451","+569","mvera@odontologia.uchile.cl",{"name":32,"role":27,"phone":20,"phoneExt":20,"email":33},"Jorge Gamonal, Specialist in periodontics","jgamonal@odontologia.uchile.cl",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":20,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Universidad de Chile","RECRUITING","Santiago","Providencia","Chile",{"type":42,"coordinates":43},"Point",[44,45],-70.64827,-33.45694,{"lat":45,"lon":44},[48],{"name":49,"role":27,"phone":50,"phoneExt":20,"email":30},"Melisa Vera Melisa Vera DSD","+56979660028",{"type":24,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"MELISA VERA","Principal Investigator, Clinical Periodontist, Universidad de Chile","100584947",false,"NCT06895980","Effect of Periodontal Treatment on Metabolic Control in Patients with Type-2 Diabetes Mellitus Treated in the Cardiovascular Healt Program","T2D","Inclusion Criteria:\n\n* 1a. Patients enrolled in the PSCV with a diagnosis of type 2 diabetes mellitus and who, in turn, have a glycated hemoglobin ≥ 7% (during the last 6 months).\n* 1b. Patients with a diagnosis of periodontitis (≥ 2 non-adjacent teeth with detectable clinical interproximal attachment loss or, attachment loss ≥ 3mm with depth to probing ≥ 3mm on free faces of ≥ 2 teeth, where the attachment loss was not attributed to non-periodontal causes (Papapanou et al., 2018)).\n\nExclusion Criteria:\n\n* 2a. Patients who have received periodontal treatment during the last year.\n* 2b. Pregnancy\u002Flactation, because they are under treatment under the Explicit Health Guarantee \"Oral and Integral Health of Pregnant Women\".\n* 2c. Therapy with antibiotics and\u002For non-steroidal anti-inflammatory drugs (NSAIDs) in the last 6 months prior to the study.","ALL","18 Years",{"count":63,"type":64},80,"ESTIMATED","INTERVENTIONAL",[67],"NA","The objective of this clinical trial is to evaluate the effect of periodontal treatment on the reduction of glycated hemoglobin levels in adult patients with concurrent type 2 diabetes mellitus and periodontitis.\n\nNon-surgical periodontal treatment and the application of a quality of life survey will be performed and then controls will be carried out for 1 year.",[70,71,72,73],"Periodontitis Chronic Generalized Moderate","Periodontitis","Periodontal Disease","Diabetes Mellitus Type 2",[75,71,76,77,78,79],"HbA1c","Cardiovascular diseases","Diabetes mellitus","type 2 diabetes mellitus","scaling and root planing","2025-03-19",{"date":82,"type":83},"2025-03-26","ACTUAL",{"date":85,"type":83},"2023-08-22",{"date":87,"type":64},"2025-12-31",{"name":5,"class":6},1]